IMRIS' neuro MR systems approved in South Korea
This article was originally published in Clinica
The Korean FDA has approved IMRIS' 1.5 Tesla and 3 Tesla IMRISneuro MRI systems. The devices allow MRI scanning of patients during neurosurgical procedures, meaning they do not have to be moved during surgery. The images help surgeons to make more accurate decisions during procedures, and decrease the probability of repeat surgeries, Winnipeg, Canada-based IMRIS says. The 3 Tesla version was approved in the US and Canada in December 2008; the 1.5 Tesla systems were already available in these countries.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.